Physician profile
David C Thornton
NPI 1265472773
$9,478.68
in general payments reported to CMS, 2019-2025
54 companies · $1,415 in 2025
The $1,415 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,997 · 2020: $588 · 2021: $613 · 2022: $1,138 · 2023: $1,965 · 2024: $1,762 · 2025: $1,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,141.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $897.77 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $589.88 | 2019-2025 | Glassia, Hyqvia, Fruzaqla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.70 | 2019-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $576.31 | 2019-2025 | Fasenra, Tezspire, Tagrisso |
| Actelion Pharmaceuticals US, INC. | $570.13 | 2019-2023 | Opsumit |
| Grifols USA, LLC | $546.94 | 2019-2024 | Prolastin-C Liquid, Xembify |
| Jazz Pharmaceuticals INC. | $498.54 | 2021-2025 | |
| Mylan Specialty L.P. | $447.73 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $433.34 | 2019-2025 | Keytruda, Verquvo, Lynparza |
| Amgen INC. | $381.50 | 2022-2025 | Tezspire, Lumakras, Tavneos |
| Regeneron Healthcare Solutions, INC. | $346.20 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $305.23 | 2019-2025 | |
| Inspire Medical Systems, INC. | $292.66 | 2023-2024 | Inspire |
| Insmed, INC. | $283.31 | 2019-2025 | Arikayce |
| Genentech USA, INC. | $226.01 | 2019-2024 | Tecentriq, Alecensa, Rozlytrek |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $213.50 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $204.51 | 2022-2025 | Acthar |
| Seagen INC. | $163.69 | 2022-2023 | Padcev, Tukysa |
| Philips North America LLC | $139.49 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $136.13 | 2019-2020 | |
| United Therapeutics Corporation | $131.23 | 2019-2024 | Tyvaso |
| Lilly USA, LLC | $126.12 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Pfizer INC. | $121.78 | 2024-2025 | |
| Baxter Healthcare | $116.18 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Abpm 6100 Blood Pressure Monitor |
| Verona Pharma, INC. | $112.09 | 2025 | Ohtuvayre |
| Shire North American Group INC | $102.51 | 2019 | |
| Servier Pharmaceuticals LLC | $88.61 | 2023-2025 | |
| Eisai INC. | $82.83 | 2022-2025 | |
| Incyte Corporation | $70.40 | 2023-2025 | Monjuvi, Pemazyre |
| Avadel Cns Pharmaceuticals, LLC | $70.03 | 2024-2025 | Lumryz |
| Paratek Pharmaceuticals, INC. | $55.43 | 2019 | |
| Ani Pharmaceuticals, INC. | $43.23 | 2025 | Purified Cortrophin Gel |
| Scpharmaceuticals INC. | $40.27 | 2023 | |
| Novartis Pharmaceuticals Corporation | $36.56 | 2019 | |
| Csl Behring | $35.15 | 2019 | |
| Exelixis INC. | $34.58 | 2021-2024 | Cabometyx |
| Gilead Sciences, INC. | $34.28 | 2019-2021 | |
| Axsome Therapeutics, INC. | $33.22 | 2024 | Sunosi |
| Daiichi Sankyo INC. | $30.94 | 2019 | |
| Viatris Specialty LLC | $24.60 | 2025 | Yupelri |
| Alnylam Pharmaceuticals INC. | $23.17 | 2023 | |
| Beigene USA, INC. | $22.68 | 2023 | Brukinsa |
| Sanofi-Aventis U.S. LLC | $21.43 | 2023 | |
| Abbott Laboratories | $21.41 | 2025 | Cardiomems |
| Boston Scientific Corporation | $20.35 | 2023 | Watchman Access System |
| Aveo Pharmaceuticals, INC. | $19.93 | 2024 | |
| Pulmonx Corporation | $19.36 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Chiesi USA, INC. | $18.00 | 2022 | |
| Janssen Biotech, INC. | $17.28 | 2025 | Rybrevant |
| Abbvie INC. | $16.54 | 2025 | |
| Electromed, INC. | $15.20 | 2019 | |
| Advanced Respiratory, INC | $14.83 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.61 | 2024 | Arcalyst |
| Vifor Pharma, INC. | $13.28 | 2024 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.